1. Home
  2. UTF vs FOLD Comparison

UTF vs FOLD Comparison

Compare UTF & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTF
  • FOLD
  • Stock Information
  • Founded
  • UTF 2004
  • FOLD 2002
  • Country
  • UTF United States
  • FOLD United States
  • Employees
  • UTF N/A
  • FOLD N/A
  • Industry
  • UTF Finance Companies
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTF Finance
  • FOLD Health Care
  • Exchange
  • UTF Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • UTF 2.4B
  • FOLD 2.5B
  • IPO Year
  • UTF N/A
  • FOLD 2007
  • Fundamental
  • Price
  • UTF $24.75
  • FOLD $8.15
  • Analyst Decision
  • UTF
  • FOLD Strong Buy
  • Analyst Count
  • UTF 0
  • FOLD 9
  • Target Price
  • UTF N/A
  • FOLD $26.44
  • AVG Volume (30 Days)
  • UTF 171.7K
  • FOLD 5.8M
  • Earning Date
  • UTF 01-01-0001
  • FOLD 11-05-2025
  • Dividend Yield
  • UTF 7.19%
  • FOLD N/A
  • EPS Growth
  • UTF N/A
  • FOLD N/A
  • EPS
  • UTF 2.84
  • FOLD N/A
  • Revenue
  • UTF $138,636,669.00
  • FOLD $571,160,000.00
  • Revenue This Year
  • UTF N/A
  • FOLD $20.98
  • Revenue Next Year
  • UTF N/A
  • FOLD $20.74
  • P/E Ratio
  • UTF $9.16
  • FOLD N/A
  • Revenue Growth
  • UTF 19.80
  • FOLD 25.35
  • 52 Week Low
  • UTF $22.05
  • FOLD $5.51
  • 52 Week High
  • UTF $26.53
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • UTF 44.56
  • FOLD 56.40
  • Support Level
  • UTF $24.22
  • FOLD $7.69
  • Resistance Level
  • UTF $24.85
  • FOLD $8.59
  • Average True Range (ATR)
  • UTF 0.37
  • FOLD 0.37
  • MACD
  • UTF 0.10
  • FOLD -0.05
  • Stochastic Oscillator
  • UTF 74.25
  • FOLD 54.44

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: